Drugs / Sabin Inactivated Poliovirus Vaccine (Vero cell)
Sabin Inactivated Poliovirus Vaccine (Vero cell)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05432141 | Jun → Sep 2022 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Inactivated Poliovirus Vaccine (Vero cell) | “Sabin Inactivated Poliovirus Vaccine (Vero cell)(sIPV)” NCT05432141 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05432141 ↗ |
| Known as | sIPV vaccine | “sIPV vaccine /DTaP vaccine” NCT05432141 ↗ |
| Modality | Vaccine | “Sabin Inactivated Poliovirus Vaccine (Vero cell)(sIPV)” NCT05432141 ↗ |
| Route | Intramuscular | “Subjects recommended intramuscular injection.” NCT05432141 ↗ |